mizoribine has been researched along with Disease Exacerbation in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imaizumi, T; Tanaka, H; Tsuruga, K | 1 |
| Clark, MR; Liarski, VM; Trotter, K | 1 |
| Arimura, Y; Kawashima, S; Yoshihara, K | 1 |
| Arakawa, T; Doi, S; Ito, T; Kawai, T; Kohno, N; Masaki, T; Nakashima, A; Takahashi, S; Taniguchi, Y; Yorioka, N | 1 |
| Fujinaga, S; Hara, S; Murakami, H; Ohtomo, Y; Shimizu, T; Someya, T; Umino, D | 1 |
| Aoki, M; Arakawa, Y; Arima, R; Fujita, E; Fukuda, K; Fukui, M; Hirama, A; Iino, Y; Kaneko, T; Mii, A; Shimizu, A; Utsumi, K | 1 |
| Ito, E; Kudo, M; Nakahata, T; Suzuki, K; Tanaka, H; Tsugawa, K | 1 |
| Ito, E; Oki, ES; Suzuki, K; Tanaka, H; Tsugawa, K; Tsuruga, K | 1 |
| Hataya, H; Honda, M; Iijima, K; Ishikura, K; Nakanishi, K; Yoshikawa, N | 1 |
3 review(s) available for mizoribine and Disease Exacerbation
| Article | Year |
|---|---|
Mizoribine in the treatment of pediatric-onset glomerular disease.
Topics: Animals; Cell Movement; Chemokine CCL2; Child; Disease Progression; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Diseases; Kidney Glomerulus; Macrophages; Mesangial Cells; Podocytes; Rats; Ribonucleosides | 2015 |
Overview of pathophysiology and treatment of human lupus nephritis.
Topics: Abatacept; Antibodies, Monoclonal, Humanized; Autoantibodies; Biopsy; Cyclophosphamide; Dendritic Cells; Disease Progression; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammation; Interferon Type I; Kidney Failure, Chronic; Lupus Nephritis; Maintenance Chemotherapy; Mycophenolic Acid; Prognosis; Quinolones; Recombinant Fusion Proteins; Remission Induction; Ribonucleosides; Severity of Illness Index; T-Lymphocytes, Helper-Inducer; Treatment Outcome; Vimentin | 2016 |
[ANCA associated vasculitis and PRGN].
Topics: Animals; Antibodies, Antineutrophil Cytoplasmic; Biomarkers; Cyclophosphamide; Disease Progression; Glomerulonephritis; Glucocorticoids; Humans; Immunosuppressive Agents; Mycophenolic Acid; Recurrence; Ribonucleosides; Vasculitis | 2009 |
1 trial(s) available for mizoribine and Disease Exacerbation
| Article | Year |
|---|---|
Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study.
Topics: Biopsy; Child; Dipyridamole; Disease Progression; Female; Follow-Up Studies; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunoglobulin A; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Glomerulus; Male; Pilot Projects; Platelet Aggregation Inhibitors; Prednisolone; Prospective Studies; Proteinuria; Ribonucleosides; Severity of Illness Index; Treatment Outcome | 2008 |
5 other study(ies) available for mizoribine and Disease Exacerbation
| Article | Year |
|---|---|
Mizoribine suppresses the progression of experimental peritoneal fibrosis in a rat model.
Topics: Actins; Animals; Cell Movement; Chemokine CCL2; Chlorhexidine; Collagen Type III; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Fibrosis; Immunosuppressive Agents; Macrophages, Peritoneal; Peritoneal Diseases; Peritoneum; Rats; Rats, Wistar; Ribonucleosides; Transforming Growth Factor beta | 2009 |
Protective effects of Mizoribine on Cyclosporine A nephropathy in rats.
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Cyclosporine; Disease Progression; Fibrosis; Immunohistochemistry; Immunosuppressive Agents; Inflammation; Kidney; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleosides | 2009 |
[Two cases of rapidly progressive nephritic syndrome complicated with alcoholic liver cirrhosis].
Topics: Adult; Disease Progression; Drug Therapy, Combination; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunosuppressive Agents; Kidney Glomerulus; Liver Cirrhosis, Alcoholic; Male; Methylprednisolone; Middle Aged; Prednisolone; Pulse Therapy, Drug; Ribonucleosides; Treatment Outcome | 2011 |
Implication of the peak serum level of mizoribine for control of the serum anti-dsDNA antibody titer in patients with lupus nephritis.
Topics: Administration, Oral; Adolescent; Adult; Antibodies, Antinuclear; Child; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Disease Progression; DNA; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Prednisolone; Ribonucleosides; Severity of Illness Index; Treatment Outcome | 2005 |
Long-term intermittent pulse therapy with mizoribine attenuates histologic progression in young patients with severe lupus nephritis: report of two patients.
Topics: Adolescent; Child; Disease Progression; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Pulse Therapy, Drug; Ribonucleosides; Severity of Illness Index; Time Factors | 2007 |